Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
Health & Biotech
Institutional investors power HeraMED’s maternity care revolution with $1m
Health & Biotech
ASX health stocks developing tech to bridge labour gaps
Health & Biotech
ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform
Health & Biotech
Health Check: Nothing to spook investors in CSL’s update as the blood still flows thick
News
ASX Small Caps Lunch Wrap: ASX up, and things are pretty quiet for a Wednesday
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
HeraMED revolutionising maternity care with digital technology
Health & Biotech
User base expands for HeraMED’s remote pregnancy monitoring platform
Health & Biotech
Check Up: Aussie biotech Ternarx to pioneer next-gen cancer medicine, and recent ASX health winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX edges lower, but uranium miners rally on Dutton’s nuclear plants pledge
News
ASX Small Caps Lunch Wrap: Which US city was home to the world’s unluckiest criminal this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Which European food-babies just can’t handle the heat this week?
News
Closing Bell: ASX buried under -1.3pc as iron ore miners and goldies take a beating
ASX Small Caps Lunch Wrap: Which prominent Transformer has been arrested this week?
News